Baosheng Liang | Biostatistics | Best Researcher Award
Assist. Prof. Dr. Baosheng Liang, Peking University, China.
Publivation Profiles
Orcid
Education and Experience
ย Education:
ย Ph.D.ย in Probability Theory & Mathematical Statistics, Beijing Normal University (2012-2016)
ย M.S.ย in Probability Theory & Mathematical Statistics, Beijing Normal University (2009-2012)
ย B.S.ย in Mathematics & Applied Mathematics, Qingdao University (2005-2009)
ย Experience:
ย Assistant Professor, Peking University (2018โPresent)
ย Postdoctoral Researcher, The University of Hong Kong (2016โ2018)
ย Joint Training Ph.D., University of North Carolina at Chapel Hill (2013โ2014)
Suitability summaryย
Dr. Baosheng Liang, an Assistant Professor in the Department of Biostatistics at Peking University, is a distinguished researcher in the field of biostatistics. With an extensive background in probability theory, statistical learning, and causal inference, he has made significant contributions to advancing statistical methodologies for biomedical and clinical research. His academic journey spans prestigious institutions such as the University of North Carolina at Chapel Hill, the University of Hong Kong, and Beijing Normal University, where he honed his expertise in survival analysis, semiparametric models, and robust statistical methods. His research has significantly enhanced the understanding of recurrent-event data analysis and meta-analysis techniques, making him a strong candidate for the Best Researcher Award.
Professional Development
Dr. Liang has significantly contributed to biostatistical research, focusing on survival analysis, semiparametric models, and causal inference. His work extends to recurrent-event data analysis, robust statistical methods, and machine learning applications. Through collaborative projects and academic publications, he has enhanced statistical modeling for healthcare and epidemiology. His methodological advancements in incomplete data analysis and subgroup analysis provide deeper insights into public health and medical research. As an academic mentor and researcher, Dr. Liang continually refines statistical learning techniques, ensuring their adaptability in real-world applications.ย 



ย Outstanding Young Researcher Awardย โ Peking University
ย Best Paper Awardย โ International Biostatistics Conference
ย Excellence in Teaching Awardย โ Peking University
ย Research Grant Recipientย โ National Natural Science Foundation of China
ย Clinical association between plan complexity and the local-recurrence-free-survival of non-small-cell lung cancer patients receiving stereotactic body radiation therapyย (2024) โย Physica Medicaย 













, is a skilled statistician and educator specializing in advanced 

ย 2007: Master in Applied Mathematics, Biostatistics, University Henri Poincarรฉ.
ย 2005: Bachelorโs in Mathematics, University Henri Poincarรฉ.
ย 2004: DEUG MIAS, University Henri Poincarรฉ.
ย 2022-Present: Lecturer in Statistics, Masterโs in Biomechanics.
ย 2014-2021: Biostatistician, CHRU Nancy, co-developing statistical tools and mentoring.
ย 2013-2014: INSERM Researcher on survival estimation methods.
ย 2008-2011: Lecturer, Aix-Marseille University, teaching mathematics and econometrics.
. Her collaboration with INRS and CHRU Nancy strengthened her expertise in survival analysis, multilevel models, and econometricsย
. Proficient in software like R, STATA, and SAS, she develops innovative solutions, including statistical packagesย
. Her commitment to applying rigorous analytical methods contributes significantly to public health and occupational safety fields.ย 

. Her expertise lies in multilevel modeling, survival analysis, and econometric methods, addressing challenges like healthcare access disparities, disease surveillance, and treatment adherenceย
. She has contributed to developing innovative tools for data analysis, enhancing predictive modeling capabilities. Isabelle’s interdisciplinary approach integrates advanced statistical methods with applied health researchย
. Her projects, from modeling antiretroviral treatment compliance to analyzing health behaviors, aim to improve public health policies and interventions, fostering equitable healthcare systems globallyย
ย 2014: Qualification for Maรฎtre de Confรฉrences by the French National University Council (CNU).